Sign in

CIK 0001671584

  • Non-accelerated filer
  • Smaller reporting company

Aptevo Therapeutics Inc.

Sign in to watch
Ticker
APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811567056
Phone
+1 206-838-0500
Business address
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
  1. 4 Shares withheld for taxes SVP and CFO gave up 2,170 shares (to pay taxes)
  2. 4 Shares withheld for taxes See Remarks gave up 2,710 shares (to pay taxes)
  3. 4 Shares withheld for taxes SVP, Commercial Operations gave up 2,395 shares (to pay taxes)
  4. 4 Open-market buy SVP Operations bought 5,000 shares at $2.37 ($11,850)
  5. 4 Open-market buy President and CEO bought 10,000 shares at $2.38 ($23,800)
  6. 4 Shares withheld for taxes SVP, GC and Corporate Affairs gave up 383 shares (to pay taxes)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Shares withheld for taxes President and CEO gave up 8,373 shares (to pay taxes)
  16. 4/A Open-market buy President and CEO bought 100,000 shares at $2.93 ($293,000)
  17. 4 Open-market sale President and CEO sold 100,000 shares at $2.93 ($293,000)
  18. 4 Derivatives Options or other derivatives
  19. 4 Option exercise Chief Medical Officer and SVP acquired 13,892 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 10 of 14 · 265 filings